Both in Biotechnology
Surrozen vs Editas Medicine
Over the past year SRZN returned +138.2% and EDIT returned −11.6%; their daily moves had a correlation of 0.29.
SRZN +138.2% EDIT −11.6%Growth of $1, one year, split-adjusted
| Metric | SRZN | EDIT |
|---|---|---|
| Price | $31.11 | $2.71 |
| Market cap | $365.6M | $415.4M |
| Today | +3.27% | +4.04% |
| 1 month | +18.0% | −0.9% |
| 6 months | −8.9% | −14.8% |
| Year to date | +37.6% | +32.0% |
| 1 year | +138.2% | −11.6% |
| Revenue growth (YoY) | +408.6% | +232.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | 640.8% | −153.3% |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | 8.8× |
| Net cash | $102.0M | $155.9M |
| Dividend yield | — | — |
| Volatility (60d) | 170.9% | 81.4% |
| Short % of float | 37.0% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).